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Omega-3 fatty acid supplements derived from algal oil are a fast-
growing nutraceutical product because they provide an alternative to fish-
meal based oil; they are sustainable, economically viable, and appeal to a 
wider consumer market. There are many factors that have been shown to affect 
the fatty acid profiles of algae: environmental stressors, nutrient 
availability, and temporal cycles. This thesis explores the effects of 
temporal culture dynamics on the fatty acid profiles of Cyclotella 
meneghiniana in both small-scale and large-scale growth models. these results 
can be used to develop a strategic growth model for the optimization of 
Omega-3 product yield in a commercial scale algal growth facility. A market 
assessment of the quality and consistency of current algal omega-3 
supplements was completed to identify possible challenges of a commercial 
algal based product. Maximizing the lipid content and optimizing the fatty 
acid profiles will have a significant impact on the quantity, quality, and 






The first time I heard the term “algae” in a positive light was in my 
junior year as an undergraduate in the BS biology program at East Carolina 
University. The professor of the global climate change class was outlining 
some potential bioremediation technologies and algae was featured as a 
possible carbon fixer/toxin remover for the environment. With a 
botany/ecology concentration, I had already discovered my love for growing 
things, but these tiny aquatic plants intrigued me, the more I learned about 
these organisms, the more fascinating they became. After my undergraduate 
education I decided that I wanted to start my own algal growth facility. To 
that end I began looking for a graduate level program that was able to offer 
a phycology focus, specifically on the growth and commercial use of algae. 
While researching the next step in producing algae commercially I came across 
an article about Dr. Julius and his phytoplankton laboratory at St Cloud 
State University, near my hometown of Big Lake MN. I reached out to Dr. 
Julius and in our first meeting expressed my interest and desire to learn 
more about algae and their potential for commercial growth. St Cloud State 
was able to offer me a flexible graduate program allowing me to pursue both 
of my passions, biology and business, simultaneously. My research combined 
work from the Herberger school of business, centering around entrepreneurship 
and new product development, with a foundation in the school of science and 
engineering curriculum. The purpose of this thesis is to highlight some of 
the research that was completed during my Master of Science degree studies. I 
am exceedingly grateful for all of Dr. Julius’ support in the completion of 
this research. This is one of the steps in my journey towards the launch of 
an innovative nutraceutical grade algal biomass facility. I will be using the 
knowledge gained from my time at St Cloud State University as a foundation 
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for the launch of a scientifically based, economically viable business in the 
algae industry. I will be refining my business plan, with the intentions to 
procure funding and execute a proof of concept commercial algal growth pilot 
facility outlined in the appendix. These core concepts will be the launching 
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Chapter 1 : Diatom growth and yield factors, a review 
Introduction 
The term “diatom” refers to organisms in the family Bacillariophyceae, 
also termed “golden algae”. Diatoms are a group of oleaginous algae, 
characterized by their distinctive silica frustules. Diatoms are one of the 
most diverse group of organisms; with over 200 known genera and an estimated 
200,000 species, of which only approximately 10% are currently described 
(Mann and Droop 1996). This group of organisms are environmentally 
significant because they provide an estimated 20% of available oxygen to the 
planet (Mann 1999). Diatoms have been of commercial interest for almost 40 
years because of the high non-polar lipid content stored in their vacuoles 
(Chisti 1980).  
The most popular commercial application for these lipids is biodiesel, 
which can be used as a direct replacement for petrol-based fuels. The lipid 
body in diatoms contains primarily triglycerides which can be reacted with 
methanol via transesterification to make fatty acid methyl esters 
(biodiesel). This process can be completed for a biodiesel yield of over 98% 
of the crude algal oil (Fukuda et al. 2001). It is estimated that if 2.5% of 
United States crop land is converted to production of algae-based biofuel, 
50% of the US petrol consumption could be replaced with biodiesel (Chisti 
2007).   
Some species of diatoms produce long chain polyunsaturated fatty acids 
(omega-3 PUFA), Specifically docosahexanoic acid (DHA) and eicosapentaenoic 
acid (EPA). These fatty acids have been used in fish feed to increase the 
omega-3 fatty acids in their tissues (Stoneham et al. 2018). Direct 
supplementation of DHA and EPA has also shown to be beneficial for brain 
health. Showing neuroprotective properties against heavy metal poisoning 
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(Singh et al. 2019) as well as treatment of some mental ailments such as 
depression (Tayama 2018). Omega-3 fatty acids have also shown to prevent 
coronary heart disease and regular intake of DHA and EPA is recommended by 
the American Health Association (Ajith and Jayakumar 2019). Commercial 
production of algal oil, specifically from diatom species with high oil 
content, have the potential to reduce our dependence on fossil-based fuels 
and provide valuable health benefits both indirectly through animal feed 
additives and directly through nutraceutical supplements. 
Lipid Production Strategies 
 Research on the lipid synthesis pathways in diatoms is relatively 
limited, current understanding suggests that their lipid biosynthesis 
Figure 1.1 Diagram of two lipid metabolic pathways in diatoms: Saturated and 
monounsaturated medium chain fatty in the chloroplast and the endoplasmic 
reticulum to convert medium chain fatty acids to long chain PUFA (Zulu et al. 
2018) 
 
Table 1.1. Economic model comparison from three different studies: Model 1 
and Model 2 were designed for biofuel production; Model 3 centered around 
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pathways contain elements from both prokaryotic (in the plastid envelope 
membranes) and eukaryotic (localized in the endoplasmic reticulum) pathways 
(Zulu et al. 2018). Fatty acid synthesis is thought to occur via prokaryotic 
pathways in the envelope membranes of the plastids similar to flowering 
plants (figure 1.1). This process produces a variety of medium chain 
saturated and monounsaturated fatty acids (MUFA), primarily 16:0, 18:0, 16:1, 
18:1. The medium chain fatty acids produced in this manner can then be 
metabolized in the endoplasmic reticulum via the eukaryotic synthesis 
pathways.  
The eukaryotic fatty acid synthesis pathway may directly associate with 
the prokaryotic pathway but no conclusive research has been found (Zulu et 
al. 2018). The endoplasmic reticulum houses the synthesis of both the 
polyunsaturated fatty acids (PUFA) as well as the triacylglycerols (TAG) 
(Figure 1.1). The synthesis of MUFA, PUFA, and TAG in diatoms has been of 
interest to the scientific community due to its potential environmental and 
commercial applications. While the exact nature of these processes is not yet 
fully understood, there several triggers have been identified for stimulating 
the production of lipids in diatoms including: silica limitation, carbon 
dioxide infusion, photoperiods, and culture age. 
Silica limitation 
Silicon depletion to stimulate lipid production in Cyclotella cryptica 
was first documented over 30 years ago. Roessler published that 4 hours after 
the silicon in the media was depleted, the lipid composition of the cells 
increased from 27.6% to 54.1%. he believed that this accumulation of lipids 
was caused by two mechanisms: the creation of new lipids in the chloroplasts, 
and the conversion of other sugars and storage products into lipids for the 
protection of the cell against the environmental stress (Roessler 1988). The 
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primary challenge of the utilization of this strategy is biomass production, 
which is limited by the initial silicon concentration.   
Ozkan and Rorrer aimed to develop a high-density diatom strategy using 
a multi-stage silicon and nitrogen feeding system to achieve high density 
culture in photobioreactors. After initial growth and nutrient depletion, a 
nitrogen and silicon mixture were infused into the bioreactor 11 times over 
the course of 10 days. Roessler’s 1988 protocol was used as control for the 
silicon deplete condition. In the silicon replete treatment, Ozkn and Rorrer 
observed a staggering 10-fold increase in yield (5g/L biomass), but that was 
accompanied by a significant drop in lipid levels at 8% in comparison to the 
39% lipids control in their control culture (2017b). 
Jeffryes et al. developed a multi-stage silicon feed protocol where 
they aimed to increase biomass while maintaining a silicon starved culture 
with high lipids. This protocol involved a 48, 72, and 96 hour window during 
which they had a slow silicon feed infused into the culture after initial 
silicon depletion. This experiment was able to maintain the silica-starved 
state in the 48 and 72 hour treatments, and they were successful at 
increasing biomass and yield while maintaining a 45% lipid biomass (2013). 
Silica limitation appears to be an effective strategy for increasing lipid 
production in Cyclotella sp. and could be used in a commercial growth feeding 
strategy to maximize yields. 
Carbon Dioxide Infusion 
Available dissolved carbon dioxide is a primary challenge to 
commercially cultivated algae systems. Most photobioreactors (and some 
raceways) use air bubblers to increase carbon availability for the algae. To 
further increase yield, CO2 can also be bubbled into the bioreactors, a 10% 
13 
 
carbon dioxide mixture was found to increase diatom yields by almost two-fold 
(Wang et al. 2014). In another study, Ozkan and Rorrer found that a 10% CO2 
infusion increased the lipid content of Cyclotella sp. while maintaining 
chitin production, thus increasing lipid yields without decreasing the 
valuable chitin co-product (2017a). Botte et al. found that while a 10% CO2 
infusion increased lipid yields by two or three-fold in Cyclotella cryptica 
it did not significantly improve the creation of new biomass. They developed 
a growth strategy that alternated nutrient additions and 10% CO2 infusions 
when the nutrients reached depletion. They were able to achieve 1.25g/L dry 
biomass without seeing a decrease in lipid yield (Botte et al. 2018). Based 
on these studies, a 10% CO2 enrichment would be an ideal addition to a 
commercial Cyclotella sp. production strategy. 
Photoperiods 
Sicko-goad et al. identified cyclic trends in their Cyclotella 
meneghiniana cultures regarding lipid content and composition that related to 
each photoperiod. By combining the control data from 4 different experiments 
and separating the data into 3 different photoperiods (early light, late 
light, and dark) they were able to identify shifts in fatty acid composition 
and abundance. They found that while the major fatty acids (C16’s) stayed 
relatively consistent, the unsaturated fatty acids (including EPA) were 
lowest in the early light period and highest in the dark period. Also the 
lipid content is highest in the dark period and lowest in the early light 
period, suggesting that the cell division events likely happen in the late 
dark or early light period (1989). Gaidarenko et al. found contrasting 
results when they evaluated these day/night cycles in their Cyclotella 
cryptica culture. They found that the lipid levels increased during the day 
and decreased at night, with a mid-day decrease in lipids while the cells 
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divided (2019). This difference in temporal reproduction rhythms are possibly 
due to taxonomic adaptations. Cyclotella cryptica is found in colder regions 
so they could have adapted their reproductive cycle to be during the warmest 
part of the day cycle. In contrast it would be more advantageous for the 
temperately located Cyclotella meneghiniana, who favor long light cycles 
(Sicko-goad and Andresen 1991) to divide when the temperature is at the 
coolest, the last part of the night, or first part of the day. These results 
suggest that identifying the optimal photoperiod cycles is essential when 
developing a commercial algal growth strategy.  
Culture Age 
Diatoms also have distinct growth phases that impact fatty acid 
composition and yield. While evaluating the ideal day/night scheme for lipid 
production, Sicko-goad and Andresen identified a specific period, after 
exponential growth when the lipid content of the biomass was the highest. For 
their culture of Cyclotella meneghiniana this period was on day 14, after 
which, lipid yield started to decrease (1991). Stepaneck et al, observed a 
similar trend when they compared Cyclotella meneghiniana and Phaeodactylum 
tricornutum DHA lipid yields based on when the culture was harvested 
(early/late exponential and early/late exponential). They found that very 
shortly after exponential growth phase has ended, lipids begin to decrease, 
specifically the long chain polyunsaturated fatty acids (DHA) (unpublished 
data). These trends suggest that careful monitoring and precise harvest 
timing can maximize product yield in commercial algal DHA production. 
Commercial Cultivation Strategies 
Maximizing lipid yield is not the only factor that can influence the 
successful commercial production of algal biomass. Bioreactor type has a 
large influence on the economic viability of the business. There are three 
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major bioreactor types that will be evaluated: fermentation bioreactors, 
photobioreactors, and raceway ponds. There are several environmental factors 
that will influence growth in all these environments including: carbon 
source, light saturation, and nutrient competition. These three factors will 
be contrasted for economic viability on a commercial scale. 
Fermentation Bioreactors 
Heterotrophic growth of diatoms was first identified in 1953 when Lewin 
tested 42 different strains for the ability to thrive in the absence of 
light. He was able to successfully cultivate 13 isolates in the dark with a 
glucose rich medium (Lewin 1953). Since that time, heterotrophic growth of 
algae has become one of the most popular cultivation methods for commercial 
algal production. Heterotrophic bioreactors are completely sealed, all 
environmental factors are controlled and measured, this allows for a very 
consistent and high-quality product (Barclay et al. 1994). The absence of 
light also allows for very high cell density because the diatoms are not 
dependent on light saturation for growth. Heterotrophically grown biomass and 
lipid yield have been published at more than 3 fold higher than traditional 
photobioreactor or raceway ponds (Morales-Sanchez et al. 2016; Barclay  et 
al. 1994). Although these high yields are very appealing for commercial 
cultivation, they are accompanied by very high capital investment and 
operational costs (Morales-sanchez et al. 2016).  Heterotrophic growth has 
several limitations including, high initial capital cost, high operational 
cost, and limited target isolates. However, if the target product has a very 




Photobioreactors are closed bioreactors made of either glass or clear 
plastic to allow for maximum light penetration, which can be supplied by 
either natural or artificial light. Tubular photobioreactors are the most 
common type and consist of large tubes that have continuously flowing culture 
medium in them (Slegers et al. 2013). Other types of photobioreactors include 
flat panel (Endres et al. 2016) and clear polyethylene bags (Harris et al. 
2013). Photobioreactor systems typically have a higher initial capital 
investment and maintenance costs than raceway ponds but have less 
contamination or environmental hazards. Closed systems also have less water 
loss and can achieve higher biomass concentrations than their pond/raceway 
counterparts (Chisti 2007). Photobioreactors also make it possible to 
cultivate algae on a commercial scale in the northern climates by heating and 
supplementing with artificial light in the winter months (Pankratz 2017). 
Viability of a photobioreactor algae production facility is largely dependent 
on the value and importance of purity in the product. 
Raceway Ponds 
Raceways generally consist of a long, shallow pond that is dug into the 
ground, or in a frame above ground, and lined with either cement or plastic, 
they maintain a continuous flow with a large paddlewheel. Open systems are 
subject to significant water loss through evaporation and their yields are 
limited by light saturation because of shading, Raceway ponds typically have 
a maximum depth of approximately 12 inches (Chisti 2007). In addition to 
depth measurements, the correct pond length to height ratio is also very 
important to minimize dead zones and maintain homogeneity of nutrients to 
maximize CO2 utilization (Hadiyanto et al. 2013).  Raceway ponds can either 
be outdoors or indoors with artificial light sources. Because outdoor systems 
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are exposed to the environmental conditions, location is very important. In a 
simulation using several environmental and operating conditions Rarrek et al. 
concluded that Les Cruz, New Mexico had optimal growing conditions for a 
raceway pond, specifically in the month of June (2016).  Location of indoor 
systems are more flexible but will require a large amount of temperature-
controlled space to function. Despite these challenges, raceways are very 
popular because of their low initial capital investment and maintenance 
costs. 
Harvesting Strategies 
In addition to taxa selection, Lipid accumulation strategy, and 
bioreactor type, harvest strategy will have a large impact on your overall 
commercial cultivation strategy. Most algal cultures follow a predictable 
growth pattern called the s-curve. When initially inoculated, the 
concentration of cells in the culture is usually very low, the growth 
experiences a lag phase where the algae are adjusting to the new environment. 
Once the concentration has reached the species dependent threshold, the 
population experiences rapid expansion, termed the “exponential” growth 
phase. In this growth stage, the cells are actively dividing and doubling 
every 24-36 hours. When the population reaches nutrient depletion, the cells 
start to transition from active growth to stationary phase. In this phase 
they will start converting all available energy into protective compounds 
(lipids in diatoms) for storage and protection. Commercial cultivation and 
harvest can be achieved through a few different strategies: Batch, 
continuous, and semi-continuous harvest. For a batch harvest, the algae are 
allowed to grow until they reach the stationary phase. Once maximum biomass 
is reached 90-95% of the cells are harvested, just leaving enough culture to 
inoculate the next batch, which will start again at the lag phase. This 
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results in a longer period between harvest times because each batch begins 
again at the lag phase.  
The second type of commercial cultivation strategy is called continuous 
culturing. In a continuous harvest, the culture is grown until it nears the 
end of exponential growth phase. Once exponential growth reaches its peak, a 
constant small harvest stream begins, the lost volume is replaced with fresh 
media to prevent nutrient depletion. This cultivation strategy can be very 
effective for blue-green or green algae, however golden algae have the lowest 
lipid content during the exponential phase.  
The third type of cultivation strategy is called semi-continuous 
culturing. In a semi-continuous harvest the culture is grown until it reached 
the stationary phase, then 40-50% of the culture is harvested and the lost 
volume is replaced with fresh media to begin the culture again at exponential 
phase, the cell concentration never falls low enough to send it back to lag 
phase. Depending on the taxa, you can either harvest at the end of 
exponential phase or beginning of stationary phase, the harvest intervals 
will be the approximate doubling time of the taxa (24 – 36 hours). With an 
oil producing taxa, the harvest frequency will be the doubling time plus the 
transition time to the stationary phase (48-72 hours). This hybrid harvest 
method effectively reduces time between harvests when compared to batch phase 
and does not require constant flow harvest or monitoring. There are many 
different growth strategies for commercial algal cultivation, strategy 




Economic analysis of commercial algal production is complex depending 
on productivity, bioreactor type, and product value. Below are three 
different cost models based on single product portfolios published over the 
last 10 years (Table 1.1). There are several major differences between these 
estimates, mostly centering around advancing techniques and taxa. In all 
cases, only biomass production was evaluated, oil content and processing cost 
vary widely depending on taxa. Model 1 was centered around biofuel production 
(Chisti 2007), target taxon was not specified but from biomass productivity 
claims this model was probably designed around a green algae, probably 
Chlorella sp. Economic model 1 did not include capital depreciation cost in 
their calculations, resulting in a much lower photobioreactor production cost 
than model 2. The second model used a conservative biomass productivity, and 
a high capital depreciation for photobioreactors (60% of total costs) 
compared to raceway ponds (20%) (Slade and Bauen 2013), resulting in a much 










Model 1 72 g/m2/d $2.95 /kg 35 g/m2/d $3.80 /kg (Chisti 2007) 
 
Model 2 20 g/m2/d $11.70 /kg 10 g/m2/d $2.26 /kg (Slade and 
Bauen 2013) 
Model 3 30 g/m2/d $2.80 /kg 12 g/m2/d $1.10 /kg (Xiang et al. 
2017) 
Table 1.2 Economic model comparison from three different studies: Model 1 
and Model 2 were designed for biofuel production; Model 3 centered around 
dietary supplement production. 
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higher photobioreactor production cost than the other two models. The third 
model estimated the photobioreactor cost to be only 3 times higher than 
raceway cost, with a higher operating cost resulting in smaller differences 
between the two production costs (Xiang et al. 2017). Based on these three 
independent economic models, commercial cultivation of algal oil is 
technically feasible depending on bioreactor type and potential product 
value. To create an economically viable business, a strategic approach toward 
strain selection, product development, process design and especially lipid 
content optimization are vital.  
Conclusion 
Commercial production of high value lipids and co-products from 
Cyclotella meneghiniana can be economically feasible if a strategic approach 
to the bioreactor design, location, and product marketing is applied. Media 
composition, feeding profiles, carbon dioxide addition, photoperiod, and 
harvest timing will all have significant impacts on the lipid composition and 
yield. Additionally, expanding the product portfolio to utilize more of the 
biomass would increase profits and decrease waste streams. Developing these 
key growth strategies and new technologies will have long term economic 
benefits including but not limited to the biodiesel, nutraceuticals and 
animal feed industries. Algal cultivation continues to further our progress 
towards the economic viability of a complete displacement of fossil-based 





Chapter 2 : Bioreactor scale-up for commercial cultivation 
Introduction 
The potential health benefits from dietary omega-3 oils is well known 
(Swanson et al. 2012). The majority of the Omega-3 supplement market is made 
using fish-derived oils, but fish do not make these oils, they acquire them 
from their diets (Jenkins and Josse 2008); algae are the primary producers of 
these essential fatty acids. Omega-3 supplements derived from algal oil are 
fast growing in popularity on the nutraceutical market (Finco et al. 2016). 
This trend stems from two main factors: sustainability and market demand. 
Demand for fish meal and oil has grown significantly over the last 50 years 
(Shepherd & Jackson 2013), this rapid growth of the aquaculture industry has 
been limited by space and resource availability (Shepherd & Jackson 2013) and 
has been shown to contribute to declining fish stocks (Adarme-Vega et al. 
2014) and environmental degradation (Cole et al. 2009). Commercial 
cultivation of algal for omega-3 supplements provide a sustainable 
alternative to fish-meal based oil (Lenihan-Geels et al. 2013). Supplements 
derived from fish meal can contain marine pollutants or toxins (Finco et al. 
2016) and cannot be used by consumers with dietary restrictions stemming from 
health (eg. shellfish allergy) or lifestyle choices (eg. Veganism). Algal 
derived omega-3 fatty acid supplements are vegan, toxin, and shellfish free, 
providing bioavailable omega-3 fatty acids without the consumption of fish 
(Lane et al. 2013, Doughman et al. 2007). These limitations on the production 
and usability of fish-based omega-3 supplements created a prime market space 
for alternative sources of omega-3s fatty acids, specifically from algal 
feedstocks. Algae oil based omega-3 
supplements stand out against their fish oil counterparts because they are 
sustainable, economically viable, and appeal to a wider consumer market. 
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Omega-3 Producing Algal Species 
Several Species of algae are currently being investigated for 
commercial cultivation of long chain polyunsaturated fatty acids (Omega-3’s 
specifically), those include Phaeodactylum tricornutum (Yongmanitchai and 
Ward 1991), Schizochytrium sp. (Sahin et al. 2018), Skeletonema menzeli(Jiang 
et al. 2016), and Nannochloropsis salina(Hoffmann et al. 2010) and Cyclotella 
meneghiniana (Phytolab Unpublished). Total fatty acids and EPA yield 
comparison are summarized on table 2.1. In a broad strain review comparing 21 
different algae species as potential biofuel feedstocks Cyclotella cryprica 
 Total lipids    
(% biomass) 
Omega-3 




























Table 2.1 Comparison of Omega-3 producing diatoms total lipids production 





was identified as one of the most promising taxa with lipids accounting for 
42% of biomass and TAG percentage (storage lipids) comprising 55% of total 
lipids (d’lppolita et al. 2015). These characteristics that Cyclotella 
appealing for use in the industrial market also translates to high yields in 
the dietary lipids space.  
Cyclotella meneghiniana has been shown to include omega-3 fatty acids 
in its fatty acid profile (Sicko-Goad et al. 1989, Phytolab Unpublished 
data). Although Cyclotella meneghiniana has a comparatively lower 
concentration of Omega-3 fatty acids  in the lipid bodies than the other 
currently targeted taxa, the yield of Omega-3 PUFA per kg of biomass of 
Cyclotella meneghiniana (7.83 g/kg) is only 15% lower than the current 
commercial strain Schizochytrium sp.(9.26 g/kg) (ref. table 2). High total 
lipids and the capacity to produce omega-3 fatty acids, Cyclotella is a 
promising potential feedstock for the omega-3 lipid nutraceutical market.  
Cyclotella Product portfolio 
Cyclotella sp. is attractive for commercial cultivation not only 
because if its high lipid content and capability of producing omega-3 fatty 
acids, but also because it produces a marketable co-product, chitin (N-acetyl 
glucosamine). This biopolymer nanofiber extrudes from the frustule pores 
(Herth and Zugenmaier 1977) and can be marketed as a joint supplement (Ozkan 
and Rorrer 2017a). Algal sourced chitin is a direct replacement for fish-
based chitin feedstocks, making it a complementary product for the Cyclotella 
portfolio. Although chitin is not economically feasible as a sole product 
from Cyclotella sp. the ability to market a secondary vegan, sustainable, 
nutraceutical supplement could enhance the business portfolio of a Cyclotella 
photobioreactor plant. Tipping cultures of Cyclotella to either favor 
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production of oils or chitin can be manipulated by altering growth strategies 
(Ozkan and Rorrer 2017b), providing the agility to adapt to market demands.  
In addition to these two products Cyclotella is also being researched 
for osteopathic bone therapies using the cleaned glass frustules in a bone 
paste that acts as a scaffolding to encourage faster bone growth (Walsh et 
al. 2018), this pharmaceutical application is currently in human research  
Product Target Market Composition 
(% Biomass) 
Source 
Lipids Nutraceuticals 42% (d’lppolitia 




et al. 1989) 
Chitin Nutraceuticals 20% (Xiang et al. 
2017) 
Marketable  74%  
 
trials and are anticipated to complete in 5-7 years.  These three potential 
products: dietary lipids, chitin filaments, and pharmaceutical treatment 
components make up approximately 74% of Cyclotella biomass (Table 2.2) making 
it a promising taxon for the development of a commercial growth strategy. The 
purpose of this study is to successfully scale up Cyclotella meneghiniana 
cultivation processes in a raceway pond photobioreactor resulting in 
comparable fatty acid profiles to established laboratory scale processes, 
specifically reflecting the peak in Omega-3 fatty acids in the early 
stationary stage of growth. 
Table 2.2 Percentage of Cyclotella meneghiniana biomass that 




Cyclotella meneghiniana strains used in this study originated from the 
SCSU cell bank. This strain was isolated from local Mississippi river samples 
via single cell isolation in 2009 and typed by Dr. Matthew Julius. Raceway 
experiments were completed during the summer semester, 2018. Set-up, data 
collection, and tear down for the raceway runs were assisted by the 
Phytoplankton Laboratory staff at St. Cloud State University. The growth 
strategies that were used involve specific macro nutrient profiles, 
temperature, light wavelength, light intensity, and agitation that differ 
from established small-scale growth (20L) protocols. The biomass from the 
small-scale cultivations were the source of the initial fatty acid profiles 
collected by the Phytolab team in 2016 and provide the foundation for 
measuring effectiveness of experimental large-scale protocols. The large-
scale processes were designed using a combination of literature research 
(chapter 1) and lab members personal expertise and experiences. A batch 
cultivation strategy was adopted (see chapter 1) was used for ease of input 
and output quantification as well as mitigating high contamination risk 
stemming from traffic and undergraduate student involvement. 
Small-Scale 
W.C medium was prepared according to published protocol (REF) in 20L 
Nalgene polypropylene carboy sterilized in an autoclave on a liquid cycle 
with a 60-minute sterilization duration. Sterile 20L glass carboys were 
filled with approximately 15L sterile W.C. Medium and inoculated with live 
Cyclotella meneghiniana culture from the phytoplankton laboratory cell bank. 
Carboys were fitted with a sterile vented cork fitted with a glass tube used 
to bubble filtered air through culture from a gas dispersion manifold and 
flow valves to adjust pressure. These air tubes were used to prevent carbon 
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limitation and settling. Filled and corked carboys were placed on wire 
shelving with horizontally mounted cool tone full spectrum grow bulbs on a 
16:8 light/dark cycle at 200μEm-1s-1.  
Large-Scale 
The commercial scale growth experiments were completed with a Microbio 
engineering’s RW29 model raceway pond with paddle. The raceway was filled 
with softened well water, Proline f/2 concentrated algae food by Pentair 
Aquatic Ecosystems, and sodium metasilicate dissolved in sterile water. 
Custom scaffolding was designed to cover the center portion of the raceway, 
mounted with 32 Kessil grow lights connected via synchronized controllers. 
Diatoms prefer the lower wavelength spectrum (Aidar et al. 2003) so a cooler 
lighting profile was utilized. A 16h:8h day:night cycle was adopted for this 
growth experiments as Cyclotella meneghiniana has shown a preference to long 
day cycles (Sicko-goad and Andresen 1991). Light intensity was adjusted 
dependent on culture density to achieve ideal light saturation (Ozkan and 
Rorrer 2017c) to minimize stress on the cells from over-exposure. Light 
saturation was measured using a Biospherical instruments QSL-2100 Scalar 
Irradiance sensor, target irradiance levels were 120-150 at the bottom of the 
raceway directly beneath the light bank. Temperature and pH were collected 
using a Neptune Apex controller with both pH and temperature probe mounted on 
the side of the pond for the entirety of the experiment. All raceway 




Inoculation of the raceway pond was performed in a three-step process 
(figure 2.1). Four small scale carboys were allowed to grow for approximately 
5 days until they were in their exponential phase. The densely growing 
carboys were transferred into a 1000L square tote filled with W.C medium. The 
top of the tote was modified to accommodate four Kessil brand cool tone 
growth lights and an access port for air lifters. Air lifters were designed 
using PVC pipe and air compressors fitted with a valve manifold. Tote culture 
was cultivated until a chlorophyll α level above 30 μg/L was reached, 
indicating that the population reached exponential growth phase. A single 
tote was used to inoculate the raceway pond for the pilot growth study. Fill 
height of the raceway after inoculation was 32 cm, resulting in a final 
volume of approximately 10,000 liters.  
Data Collection 
Data for these conclusions originated from two separate experiments. 
small-scale data were obtained from SCSU phytoplankton laboratory staff, 
generated in the summer semester of 2016. The Phytolab staff conducted a time 
wise study comparing fatty acid profiles of multiple omega-3 PUFA producing 
Figure 2.1 The three-step inoculation of a commercial scale raceway includes 
multiple 20L small scale reactors into an intermediary 1,000L growth tote, 
that then inoculates the 10,000L raceway. 
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algae, they identified the ideal harvest window for maximum omega-3 fatty 
acid content was 1-3 days after stationary phase begins. large scale data 
were collected from this set of large-scale raceway experiments conducted 
during the summer/fall semester 2018. 
Cell Dry Weight 
Samples for cell dry weights were filtered using a Pall magnetic filter 
funnel on a side-arm flask attached to house vacuum. Pre dried and weighed 
Gelman Sciences type A/E glass filters were placed into the apparatus and 
samples were places on pre-wetted filters; volume of sample used was 
dependent on call density. Filters with collected biomass were returned to 
60°C drying oven for 24 hours before final weight was recorded. Titer was 
determined using the change in filter weight, standardized for volume of 
sample used. 
Chlorophyll α 
The Chlorophyll α measurements were taken in duplicate using an 
AquaFluor Handheld Fluorometer by Turner Designs that collects in vivo 
chlorophyll α estimations using pulse florescence. All samples were collected 
approximately one meter beyond the paddlewheel 5 cm below the surface with 
sterile serological pipettes. All timepoints were collected at 24-hour 
intervals midway through the light cycle to standardize day/night variances. 
Oil Extraction 
Samples for small-scale fatty acid profiles were collected at 
exponential phase, first day of stationary phase (early) and Seventh day of 
stationary phase (late). Samples from large-scale experiment were collected 
on third day of stationary phase. Samples were dewatered using centrifugation 
followed by lyophilizing to remove remaining water from pellet. Oil was 
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extracted from dry biomass using an HCL direct derivatization method (Boulom 
et al. 2014). Dried biomass was combined with toluene, hydrochloric acid, 
methanol, pentadecanoic acid (internal standard), and sealed with a nitrogen 
infused headspace. After heating in water bath for approximately 2 hours, 
potassium carbonate and toluene were added to the sample and centrifuged. Oil 
layer was removed and used for fatty acid analysis.   
Fatty Acid Profiles 
The fatty acid methyl ester (FAME) composition of each sample was 
obtained with a Agilent 6890N gas chromatograph with a flame ionization 
detector, equipped with a phenomenex ZB-WAX capillary column. The sample 
inlet temperature was set to 250°C and the split ratio was 1:50. The internal 
chamber temperature was set to 70°C for 1 minute, then increased to 200°C 
with a ramp rate of 35°C/min. Once the chamber reached 200°C, an additional 
ramp of 5°C/min to 260°C. Peaks were mapped by comparing retention times to a 
Supelco 37 FAME mix (Sigma), along with a stearidonic acid methyl ester 
standard (Cayman Chemical). Fatty acids were quantified using the following 
equation: 
 𝐹𝐴 𝑐𝑜𝑛𝑡𝑒𝑛𝑡 (
𝑚𝑔
𝑔




𝐴𝑟𝑒𝑎 𝑜𝑓 𝑈𝑛𝑘𝑛𝑜𝑤𝑛 𝐹𝑎𝑚𝑒
𝐴𝑟𝑒𝑎 𝑜𝑓 𝐼𝑆 𝑥 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝐹𝑎𝑐𝑡𝑜𝑟 𝑥 𝐷𝑒𝑟𝑖𝑣𝑖𝑡𝑖𝑠𝑎𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑒
𝑀𝑎𝑠𝑠 𝑜𝑓 𝐴𝑙𝑔𝑎𝑒 (𝑔)
 
This has been modified to include the derivation rate which was 
calculated by comparing the peak area of pentadecanoic acid (internal 
standard) against the methyl pentadecanoate (external standard). Response 
factor was calculated using the areas of the FAME standard peaks and 
concentration from corresponding data sheet. Total omega-3 fatty acid content 
was calculated by summing the three different omega-3 PUFA types: 
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eicosatetraenoic acid (20:4ω3), eicosapentaenoic acid (20:5ω3), and 
docosahexaenoic acid (22:6ω3). 
Results 
Chlorophyll α measurements were used to construct growth curves for the 
large-scale experiments (Figure 2.2). Growth curves were standardized at the 
beginning of exponential phase, defined by a starting chlorophyll α 
measurement over 4 μg/L. Growth data were tested for differences using a 
linear regression analysis of covariance (ANCOVA). The growth curves from the 

























Figure 2.2. Growth curve comparison in duplicate large-scale raceway 
experiments. Experiment 2 was terminated on day 7 for fatty acid analysis. 
Linear regression analysis of covariance (ANCOVA) analysis determined no 
statistically significant difference between the two growth curves (p=0.38). 
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Small Scale Profiles 
 Fatty acid profiles obtained from small-scale experiments (Table 2.3) 
previously obtained from the Phytolab team show that the means of the omega-3 
PUFA vary significantly dependent on growth stage (Figure 2.3). These means 
of the experimental values were tested for significant differences using 
student’s t-test. There was a statistical significance between the omega-3  
           Large-scale Small-scale   
 Early Stat Exp Early Stat Late Stat 
14:0 12.9 19.86 20.045 18.585 
15:0 0 0.68 0.835 1.02 
16:0 30.2 24.3 16.6 23.8 
16:1 22.0 24.0 17.3 21.4 
16:2 4.1 4.1 3.0 0 
16:3 5.0 10.7 13.3 6.8 
16:4 2.0 1.8 4.7 3.0 
18:0 0 0 0.6 1.2 
18:1 0.7 0 1.0 3.2 
18:2 2.4 0 0 0.6 
18:4 6.4 8.1 4.3 3.1 
20:4ω3 0 0 0 0 
20:5ω3 12.3 6.4 16.9 14.6 
22:6ω3 1.5 0 1.7 2.4 
Table 2.3. Fatty acid profiles from small-scale and large-scale experiments 
performed in the Phytoplankton laboratory delineated by growth stage: 
exponential (Exp), early stationary (Early Stat) and late stationary (Late 
Stat). All values are percentage of total fatty acids. 
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fatty acid content at the 99% confidence level between the exponential and 
early stationary growth phase (p=0.008). There was also significant 
difference between the late stationary phase and exponential as well as early 
stationary phase at the 95% confidence level, p=0.014 and p=0.02 
respectively. 
Large-Scale Profiles 
 Large-scale experiments resulted in one set of duplicate fatty acid 
profiles collected on third day of stationary phase. These profiles were 
compared to the small-scale late stationary profiles for rank differences 
across the fatty acid fractions (Table 2.3). These profiles were tested for 
significant rank difference using the Wilcoxon signed rank test, no 
significant difference in fatty acid ranking between the large-scale and 
small-scale fatty acid profiles was found(p=0.916). The means of the Omega-3 
PUFA were compared between the small-scale and large-scale experiments at the 
early stationary growth stage (Figure 2.4), there was not a significant 
Figure 2.3 Omega-3 polyunsaturated fatty acid (PUFA) content of small-scale 
experiments measured in each growth stage: exponential, early stationary 
(early stat) and late stationary stage (late stat). *significant difference 
(p<0.05) **very significant difference (p<0.01) 
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difference between small-scale early stationary and the large-scale Omega-3 
PUFA fractions at the 95% confidence level (p=0.18).  
Discussion 
There were two critical comparisons evaluated in these experiments: 
consistency across the duplicate large-scale raceway experiments and fatty 
acid profile consistency between the raceway experiments and the previous 
small-scale experiments.  
Large-Scale Consistency 
The first comparison determined the repeatability of the scale-up 
efforts, verifying that the production strategy was able to be implemented in 
a repeatable fashion with consistent results. Although there were some 
individual time points that showed a significant difference with the t-tests, 
the overall slope of the growth curves was not statistically significant when 
compared with the ANCOVA analysis of co-variance. These differences of the 
individual time points may be attributed to a few different factors including 
temperature, nutrient concentrations, or Illumination variability. The first 
Figure 2.4 Comparison of the mean omega-3 fatty acid content of large-scale 
and small-scale experiments during the early exponential growth phase. † 
indicates no statistically significant difference (p>0.05). 
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large scale experiment was conducted in the spring of 2018, the initial water 
temperature was 65 Fahrenheit. The second run was completed in summer 2018, 
the initial water temperature was three degrees higher, and may have caused a 
decrease in growth. The water temperature of both experiments normalized by 
the third day of growth. The second possible reason for the discrepancy in 
max growth could be the nutrient concentration. The nutrient components used 
in the experiments were measured accurately, however, we were not able to 
measure the total water volume in the raceway accurately. The volumes are 
estimates calculated using the height of the water and total surface area of 
the raceway. If the second raceway experiment had less total volume with the 
same amount of media components, the yield per liter would predictably be 
higher. The third potential reason for the variability would be illumination 
differences, a responsive lighting profile was used to increase the 
illumination intensity as the biomass concentration got higher. On day three 
of the second experiment the lighting profiles were manipulated to provide 
maximum illumination instead of the 20% that was targeted by the lighting 
strategy. This deviation from the process was in place for 2-6 hours before 
returning to the correct settings, this difference may have impacted the 
growth curve data. Even with some individual time point differences in 
chlorophyll α and titer, the differences in growth curves were not 
statistically significant indicating that this large-scale growth strategy is 
consistent and repeatable for cultivation of Cyclotella meneghiniana. 
Small-scale vs. Large-scale Profiles 
The small to large scale fatty acid comparison is to determine if the 
omega-3 content and oil quality was preserved in the scale-up effort. The 
fatty acid profiles collected by the SCSU Phytoplankton laboratory team 
identified a distinctive shift in polyunsaturated fatty acid content 
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dependent of the growth stage that the culture was in. While the cells were 
in exponential growth the EPA content was very low, this could be due to the 
growth and cell division that happens during this growth phase. The fatty 
acid profile from the early stationary stage show a large shift from the 
saturated and monounsaturated fatty acids to the long chain polyunsaturated 
fatty acids (EPA), when the cells reach nutrient depletion, cell division 
slows, and all excess energy is converted to lipids for storage. When the 
culture proceeds into late stationary phase, there is a significant drop in 
EPA concentration, the cell begins using the long chain fatty acids to fuel 
their metabolic processes in response to the unfavorable environmental 
conditions and the omega-3 fatty acid concentration begins to fall.  
The large-scale experiment was harvested during early stationary phase, 
so the fatty acid profiles were compared to the early stationary profiles. 
The Wilcoxon rank sum tests confirmed the quality of the profiles, the two 
fatty acid profiles were similar in structure and ranking. The mean EPA 
content of the two experiments were also not significantly different with a 
95% confidence interval. Potential sources of variability include: Growth 
matrix, light quality, and harvest timing. The large scale and small-scale 
experiments use different growth media. The small-scale media has a more 
complex macronutrient profile than the large-scale experiments, which could 
have impacted lipid profiles. The small-scale experiments use full spectrum 
florescent lighting as opposed to the targeted spectrum Kessil lights used on 
the large-scale experiments, this difference could have impacted the growth 
and lipid profiles. The small-scale samples for fatty acid analysis were 
collected on the first day of stationary period, the large-scale experiment 
was harvested of the third day of stationary, this likely introduced 
variability into the fatty acid profile data. The comparison between the 
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small-scale and large-scale fatty acid profiles and omega-3 content was 
consistent across experiments, there was no statistically significant 
differences resulting from the scale-up process. 
Conclusion 
The results of this study confirm the feasibility of scaling up 
Cyclotella meneghiniana for commercial production of Omega-3 fatty acids. 
With further process optimization, the product yield and quality from 
Cyclotella may exceed all other currently researched and grown omega-3 
producing taxa. This oil data, in combination with the other two potential 
co-products (chitin and pharmaceutical additives) makes Cyclotella 
meneghiniana a versatile and marketable taxon for commercial algal 
cultivation. Algal based omega-3 fatty acid supplement market is growing in 
response to an increased consumer health-awareness and environmental 
responsibility. The commercial cultivation of algae satisfies the market 
demand for pure and sustainable nutraceutical products and Cyclotella 





Chapter 3 : Consistency and quality of dietary supplements 
Introduction 
Fatty acids are vital for the proper functioning of all living things, 
they make up the membrane around our cells, keeping the contents of the cell 
protected from the environment while maintaining permeability and nutrient 
uptake into the cell. The structure of these membranes consists of a double 
layer of phospholipids that differ dependent on the fatty acid composition. 
Fatty acids come in two types: saturated and unsaturated. The difference 
between these two types is the presence or absence of double bonds along the 
carbon chain. Saturated fatty acids have no double bonds, they are saturated 
with hydrogen. Saturated fatty acids are completely straight, and pack 
together tightly making them solid at room temperature. These fatty acids are 
used in the cell membrane for strength and stability. Unsaturated fatty acids 
lose hydrogen ions, forcing them to form double bonds along their carbon 
chain. The double bonds are shorter and less flexible thank single bonds 
making a kink in the chain, these types of fatty acids do not fit together as 
tightly, unsaturated fats are generally liquid at room temperature because of 
this. Unsaturated fats are vital because they make the cell membrane flexible 
and permeable. Unsaturated fats can be further delineated into two groups, 
monounsaturated and polyunsaturated fatty acids. Monounsaturated fatty acids 
(MUFA) have one double bond and have one kink in their chain. Polyunsaturated 
fatty acids (PUFA) have more than one double bond in each chain, giving them 
a more twisted or kinky structure. Both saturated and unsaturated fatty acids 
are needed for a healthy cell membrane. 
Essential Fatty Acids 
There are two types of polyunsaturated fatty acids (PUFA) have been 
termed “essential fatty acids” (EFA) because humans (and most animals) cannot 
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synthesize them, they must be sourced through diet. The two types of EFA’s 
are the Omega-6 and Omega-3 PUFA. The numerical designation on these classes 
refer to the location of the first double bond along the carbon tail. On an 
omega-6 fatty acid, there are six single bonds from the end of the tail 
before the first double bond is found, similarly, there are three single 
bonds before the first double bond on omega-3 fatty acid chains. Linolenic 
acid (LA) is the shortest omega-6 fatty acid, it can be found many different 
common dietary oils like corn, canola, peanut, and soybean. LA can then 
converted into longer chain omega-6 fatty acids like gamma-linoleic acid 
(GLA) and Arachidonic (AA) that are vital for cell health. Alpha-linolenic 
acid (ALA) the smallest omega-3 fatty acid, is found in Chia and flax seed 
oils. ALA can be metabolized into longer chain omega-3 fatty acids like 
eicosatetraenoic acid (DPA), eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA). These essential fatty acids are integrated into the cellular 
membrane of the tissues from many difference systems including nervous, 
immune, cardiovascular, and optical (Surette 2008). These membrane lipids 
primary role is the uptake and regulation of metabolic pathways, making them 
a vital component in the function of the cell (McArthur 1999).  
Before the agricultural revolution, the human diet consisted of an 
Omega-6:Omega-3 ratio of around 1 – 2:1, modeled by remote Greenland eskimos 
(Simopoulos 1999). The modern American diet consists of mostly corn, peanut 
and canola oil with very low flax, chia, and fish consumption, resulting in 
an Omega ratio as high as 25:1 (Simopoulus 1991). This over consumption of 
omega-6 oils and lack of omega-3 oils are suspected to contribute to chronic 
inflammatory and autoimmune diseases, cardiovascular disease, 
neurodegenerative diseases and some developmental disorders (Simopoulus 
1999). Omega-3 fatty acids have shown to exhibit neuroprotective properties 
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in the retina and improve overall eye health (SanGiovanni & Chew 2005). Long 
chain omega-3 fatty acids have been shown to decrease cardiovascular disease 
and infarction risk (Psota et al. 2006).  Omega-3 PUFAs contribute to healthy 
neurodevelopment in neonatal and adolescents (Kitajka et al. 2004). They have 
also been shown to mitigate deleterious neurological processes in adults 
like: stress responses, mood regulation and depression as well as the 
prevention of dementia and Alzheimer’s disease (Bourre 2005).  In addition to 
the optical, neurological and cardiovascular benefits, Omega-3 oils also have 
anti-inflammatory properties and could assist in the management of chronic 
inflammation and autoimmune diseases like Chron’s disease, Lupus, and 
rheumatoid arthritis (Simopoulus 2002). Although the human body can convert 
the short chain EFA’s into longer chains, the efficiency of this process is 
less than 6% conversion to EPA and less that 3.8% to DHA. This process has 
shown to be prohibited by 40-50% by the presence of excess omega-6 PUFA 
(Gerster 1998). Direct consumption of longer chain omega fatty acids has 
become a huge market share of the nutraceutical markets because of this lack 
of omega-3 fatty acids in the western diet. 
Nutraceuticals 
Nutraceuticals are naturally sourced alternatives to pharmaceuticals 
that claim physiological benefits. The global nutraceutical market size by 
2025 is projected to be 578 Billion. With the rise in healthcare costs, there 
is a health movement to find alternatives to pharmaceutical medications. In 
2018, the market size of omega-3 supplements was 2.29 Billion, this is 
expected to increase by 7.4% by 2025 (Grand View Research, 2019) Most of 
these supplements are derived from Flax oils, fish oils, and algae oils 
because of their high omega-3 content. 
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The nutraceutical industry is far less regulated by the FDA than the 
pharmaceuticals, they are grouped with food products and dietary supplements 
therefore there has been some concern over the consistency and quality of 
these minimally regulated nutraceutical supplements. Poor quality and/or 
dosage inconsistencies were identified in St John’s wart (Scotti et al. 2019, 
Booker et al. 2018), Ginko biloba (Booker et al. 2016a), ginger (Trucksess et 
al 2009), berberine (Funk et al. 2018), and Rhodiola rosea (Booker 2016b) 
nutraceutical supplements. Kleiner et al. found that over 70% of DHA and EPA 
supplements currently on the market did not contain as much active compound 
as the label stated (Kleiner et al. 2014). While the quality and contents of 
DHA and EPA supplements were compared across manufacturers, there have been 
no investigation into the specific fatty acid profile variability of these 
supplements across lots and across processes. Data strongly suggests that 
culture growth phase significantly effects diatom oil composition (chapter 
2), an investigation into whether significant variability is currently 
occurring across manufacturer batches would be prudent. 
Commercial Cultivation 
In this evaluation two different commercially available algal omega-3 
supplements will be evaluated for consistency and compared to Cyclotella 
meneghiniana oil. Three factors that could potentially affect the fatty acid 
composition and omega-3 content of commercially produced algal oil, include: 
growth style, bioreactor type, and harvest timing consistency. Two different 
growth styles will be represented, heterotrophic and autotrophic. 
Heterotrophic growth have a very high production cost due to large 
carbohydrate requirements in the growth matrix, but they can also reach much 
higher density because they are not reliant on light availability, 
autotrophic cultivation is illumination dependent so when the cell density 
41 
 
gets too high the cells closer to the light shade the rest of the 
cultivation, limiting growth. Three bioreactor types will be compared in this 
study: Fermenter, bioreactor, and photobioreactor. Fermenters facilitate 
heterotrophic growth and are impermeable to light. Bioreactors utilize 
natural light, and can be season or weather dependent, potentially 
contributing to product variability. Photobioreactors use artificial light 
for autotrophic growth which provides weather independent illumination, but 
wavelength and strength of light are dependent on equipment quality. Both 
heterotrophic and autotrophic algal growth will go through similar s-curve 
growth trends (chapter 1), and the fatty acid profiles and omega-3 
concentrations will vary dependent on harvest timing. While not specifically 
evaluated in this study, harvesting timing has shown to have a significant 
impact on fatty acid profiles, specifically in omega-3 production which is 
highest at the transition point between exponential and stationary growth 
stages (Chapter 2). Depending on harvest timing in each respective process, 
inconsistencies would result in a variable omega-3 content of the algal 
biomass. The three taxa evaluated were Schizochytrium sp, Nannochloropsis sp. 
and Cyclotella meneghiniana. 
Methods 
Algal oil from three different taxa were evaluated, two commercially 
available omega-3 nutraceutical supplements, Schizochytrium sp. and 
Nannochloropsis sp. Cyclotella meneghiniana biomass produced by the SCSU 
Phytolab (Chapter 2) was also included for comparison. 
Schizochytrium sp. 
Schizochytrium sp. sourced oil was obtained from a commercially 
available omega-3 nutraceutical dietary supplement. This biomass was produced 
in fermenters and was grown with a heterotrophic growth strategy. Three 
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different bottles of this nutraceutical supplement were obtained from local 
pharmacies, each bottle contained a different lot number. This supplement has 
an added ingredient “High Oleic Sunflower oil” as a filler. Data was 
collected in duplicate from each lot, in the form of two separate pills from 
each bottle. 
Nannochloropsis sp. 
Nannochloropsis sp. oil was extracted from a commercial omega-3 
supplement obtained from local pharmacies. This biomass was grown 
autotrophically in outdoor raceway ponds and has no added ingredients or 
fillers. Two bottles with different lot numbers were purchased and two pills 
from each bottle were evaluated for fatty acid profiles.  
Cyclotella meneghiniana 
Cyclotella meneghiniana biomass was produced using a raceway 
photobioreactor and small-scale photobioreactors. Both small-scale and large-
scale early stationary fatty acid data was used for analysis, no 
statistically significant differences were found between these two growth 
types (chapter 2) and they were used as 2 different lots when compared to 
commercial equivalents. Oil was extracted from biomass using a HLC direct 
derivatization method (Chapter 2). 
Omega-3 Data 
Bottle values for Omega-3 content of each supplement was given in 
milligrams per serving. contents were removed from pills and weighed 
resulting mass was used to determine serving size. With this baseline, listed 
omega-3 percentages were calculated by dividing omega-3 content per serving 
by serving size, the resulting ratios were used as the literature values for 
consistency comparisons. Oil was extracted directly from gel capsules of 
commercial pills using a syringe. Fatty acid profiles were obtained by HPLC, 
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methods outlined in Chapter 2. Data collected was compared to published 
omega-3 content located on bottle label and tested for significant 
differences using a two-way t-test. Consistency between and within bottles 
were compared using standard deviation. 
Results 
Schizochytrium sp.  
The Schizochytrium sp. calculated literature value was used as a 
population mean for a two-way single sample t-test to determine if the mean 
of measured oil was statistically different than the claimed literature value 
across 6 samples representing 3 different production lots (Figure 3.1). The 
average value of total omega-3 content in sampled soft gels were 51.4%, which 
was not significantly different than the bottle value of 55% (p=0.45). 




















































Figure 3.1 Comparison of Schizochytrium sp. Omega-3 PUFA content between 
claimed values (bottle) and actual values (measured). *significant difference 
(p<0.05) **very significant difference (p<0.01) † indicates no statistically 
significant difference (p>0.05) 
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lipids, significantly less than actual measured ratio of 40.2% this 
difference was statistically significant at a 99% confidence level (p=0.005). 
In contrast, the DPA (20:4ω3) content which was listed on the bottle as “other 
omega-3’s was measured at 5.2% of lipids, which was less than the bottle’s 
literature value of 10%, this difference was statistically significant at a 
95% confidence level (p=0.045). Finally, DHA (22:6ω3) content was claimed by 
the vendor to be the most prevalent omega-3 PUFA present at 30% of total 
lipids, compared to the measured value which averaged at 6%, which was 
statistically significant at a 99% confidence level (p=0.00003). There was a 
very high variability of the oil samples across lots and within lots ranging 
from 20% to 80% of mean (Figure 3.1). 
Nannochloropsis sp. 
Calculated literature values were compared to sample values of 6 
samples across 2 different production lots. Resulting values and standard 
deviation of the data is summarized on Figure 3.2.  These data follow the 
same trends as the Schizochytrium sp. data in that the average EPA (20:5ω3) 
content in the samples was 18.3% of total lipids, significantly higher than 
the claimed value of 16% at a 99% confidence level (p=0.00001). in contrast, 
the DHA (22:6ω3) concentration measured were 10.7% which was significantly 
lower than the packaging claim at 12.5% of total lipids, this value was also 
significant at a 99% confidence level (p=0.0005). Like the previously 
analyzed strain the total omega-3 fatty acid content of Nannochloropsis sp. 
soft gels was not significantly different than the claimed content at the 95% 
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confidence level (p=0.05). The standard deviation of the Nannochloropsis sp. 
samples were very small, ranging from 1% to 4.5%.  
Product Comparison 
In a comparison across commercial omega-3 producing taxon, there were 
significant differences between the mean EPA concentrations (Figure 3.3). 
There were statistically significant differences at the 99% confidence level 
between Schizochytrium sp. and both the Nannochloropsis sp. and Cyclotella 
meneghiniana (p=0.0012 and p=0.0047 respectively). However, the difference 
between the mean EPA levels of Nannochloropsis sp. and Cyclotella 
meneghiniana were less pronounced but still significant at the 95% confidence 
level (p=0.0109). The DHA ratios between the three taxon were distributed 
differently (Figure 3.3), Nannochloropsis sp. had the highest mean DHA 





















































Figure 3.2 Comparison between Nannochloropsis sp. commercial omega-3 
supplement's claimed oil content (bottle) and actual (measured). *significant 
difference (p<0.05) **very significant difference (p<0.01) † indicates no 
statistically significant difference (p>0.05) 
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Nannochloropsis sp. and the Schizochytrium sp. at the 95% confidence level 
(p=0.0213); as well as the Cyclotella meneghiniana at the 99% confidence 
interval (p<0.0001). There was no significant difference between the mean DHA 
content in Schizochytrium sp. and Cyclotella meneghiniana (p=0.0770).  
Discussion 
Schizochytrium sp. 
Even though the total omega-3 content of the Schizochytrium sp. based 
algal supplement were similar to the claims on the nutrition label, the 
specific fatty acid claims were very different. This manufacturer claims that 
the most prevalent type of fatty acids in their oils are DHA, the longest 
chain omega-3 with the highest degree of unsaturation (30% of oil) but that 
Figure 3.3 Eicosapentaenoic acid (EPA) and polyunsaturated fatty acid 
(PUFA) content of different commercial algal oil feedstocks represented in 
figure (1). Docosahexaenoic acid (DHA) polyunsaturated fatty acid content 
in figure (2). Error bars represent standard deviation across samples. 
*significant difference (p<0.05) **very significant difference (p<0.01) † 
indicates no statistically significant difference (p>0.05)  
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was simply not true, the highest concentration of DHA found in these 
supplements was 11%, the lowest was 0.8%. In contrast these supplements had 
the highest amount of EPA, the shorter chain omega-3 fatty acid, the lowest 
concentration of EPA was 23% and the highest was 56% which is a much larger 
concentration than the bottle’s claim of 15%. The combination of large 
variability and inaccurate labeling on the bottle suggests that the 
commercial growth and harvest strategy do not provide optimal or consistent 
results in their heterotrophic cultivation process. 
Nannochloropsis sp. 
Similar to the commercial omega-3 oil produced by Schizochytrium sp. 
biomass, the Nannochloropsis sp. oil’s total omega-3 content was not 
significantly different than the concentrations claimed on the label. 
However, the specific ratios of omega-3 PUFA differ significantly from the 
claimed values, the EPA was significantly higher than claimed and the DHA was 
significantly lower. Although the fatty acid ratios are not what the bottle 
claims, the standard deviation of the tested samples was very low, suggesting 
a stable process strategy with regular harvest intervals and consistent 
biomass harvest.  
Product Comparisons 
The differences between Cyclotella meneghiniana and the current omega-3 
producing commercial strains are significant. However, Cyclotella has not 
gone through a product optimization process like Nannochloropsis sp. and 
Schizochytrium sp. Table 3.1 outlines the difference in omega-3 production 
between the published literature values and the current measured values from 




The commercial Schizochytrium producers increased omega-3 concentration in 
the total lipids by 63% from published values and Nannochloropsis 
manufacturers successfully increased omega-3 production by approximately 
345%. This type of optimization can be achieved a few different ways, strain 
selection or modification, process optimization, growth and harvesting 
strategies. 
Conclusion 
This market analysis of current commercial omega-3 supplements has 
shown that while both supplement oils contain the same concentration of 
omega-3 PUFA that they claim on the label, neither of them were accurate in 
the fatty acid composition contained in their supplement. In both cases there 
were more EPA fatty acids than claimed and less DHA fatty acids than the 
label stated. This discrepancy could be from several factors including growth 
 Published 
Omega-3 
















8.4%** 29% +345% **(Hoffmann 
et al. 2010) 
Cyclotella 
meneghiniana 
18.2%*** 16.2% -12% ***(Sicko-
goad 1989)  
Table 3.1 Estimate of current omega-3 biomass yield of optimized commecial 
strains (Schizochytrium sp. and Nannochloropsis sp.) and potential 
commercial strain Cyclotella meneghiniana. 
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and harvest timing and inconsistencies in their processes. There was also a 
very large amount of variation in the heterotrophically grown Schizochytrium 
sp. suggesting the need for additional process optimization. When these 
currently commercially produced strains were compared to the potential 
commercial omega-3 producing strain Cyclotella meneghiniana, the differences 
were pronounced, however, with a concerted strain and process optimization 
strategy Cyclotella meneghiniana could be competitive in the omega-3 
nutraceutical market, it can also generate additional revenue streams in the 
joint supplement and nutraceutical additive markets, which would increase 
profit margins and decrease waste streams by utilizing more of the algal 
biomass.  This commercial omega-3 supplement research further affirms the 
conclusion that Cyclotella meneghiniana has the potential to perform 
competitively in the omega-3 nutraceutical market space; solidifying the 
scale-up potential of this organism for commercial algal cultivation with 
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Appendix: Start-up Summary for a Pilot Facility 
Objectives 
• Apply for an agricultural grant for the establishment of a 
sustainable, female owned agricultural business. 
• Rent greenhouse facility for pilot facility. 
• Implement cultivation strategy that results in biomass containing at 
least 50% lipids (w/w), 5% EPA (w/w), and 10% chitin (w/w) with 90% 
harvest recovery rates. 
Mission 
To provide high quality sustainable algal biomass for human health 
and nutrition; grown using environmentally and economically sustainable 
growth and harvest techniques. 
Keys to Success  
• Establishing effective cultivation and harvest strategy that 
demonstrates achievability of harvest yields. 
• Leverage local and national agricultural grant programs to establish 
small scale algal growth facility. 
Company Summary 
Phycologics inc. is a small, family owned and operated business. We 
grow local strains of algae to prevent negative environmental impact due 
to invasive species. We also only use sustainable growth and harvesting 
techniques to achieve our goal to be carbon neutral and environmentally 
responsible. Phycologics inc. provides omega-3 enriched oil and 
glucosamine for use in the nutraceutical market. these products 
are sourced from pure algal cultures, they are sustainable, vegan, and 




Phycologics inc. is a privately family owned for-profit corporation 
with the following executive structure.  
• CEO: Mary Calva 
• CFO: Kristine Holmes 
• COO: DeAnna Dvorak 
All three officers are owners of this corporation and maintain equal 
voting rights. 
Startup Summary 
Three major factors will contribute to the initial start-up financing 
of $215,000 (table 4.1) for this pilot facility: a strategic location, local 
and state grant awards, and small business loans. It is our intention to 
identify and rent a commercial greenhouse facility for the pilot phase of 
this start-up, this will provide a relatively protected environment for the 
growth and harvest of the algae. These rented greenhouses will be used for 
the pilot facility, including: Inoculate production tanks, raceways, and 
harvesting equipment. All this equipment will be housed in commercial 
greenhouse structures. There are numerous local and state grants available 
for sustainable agriculture as well as bioremediation and biochemical 
innovation. One opportunity of interest is the MN department of agriculture's 
"AGRI Bioenergy/Biochemical Pilot Project Grant" that provides up to $150,000 
to small agricultural startup facilities. In addition to private small 
business loans, we intend to pursue a MN department of agriculture reduced 
interest loan program (eg. "beginning farmer loan program"). Utilizing these 
resources for the startup of the initial pilot plant will enable the 
completion of a proof of concept effort that can be leveraged to secure 
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startup financing for Phycologics inc to launch an agricultural commercial 
scale algal growth facility. 
Start-up Financial Requirements 
Approximate financial start up requirements for pilot scale algal growth 
facility are outlined below. Legal expenses include contract reviews and 
incorporation fees. Insurance includes liability coverage for high risk, 
health supplement manufacturer up to $150,000 revenue. Rent and utilities was 
estimated for a 4,500 ft2 commercial greenhouse facility for 1 year. Long term 
Assets include, Small scale inoculate tanks, Raceway commercial bioreactors, 
light banks, harvesting centrifuge and pump. All costs are estimates and will 
depend upon available financing. 
Startup Requirements  
Startup Expenses  
Legal $5,000  
Stationery etc. $500  
Insurance $7,500  
Rent and Utilities $30,000  
Computer $2,500  
Other $1,000  
Total Expenses $46,500  
Startup Assets  
Cash Required $5,000  
Chemicals and Nutrients $1,500  
Long-term Assets $162,000  
Total Assets $168,500  
Total Requirements $215,000  
 
